India  

US FDA approves a weight loss drug for treating ‘serious’ fatty liver disease; here’s what you need to know

IndiaTimes Wednesday, 20 August 2025 ()
The FDA has approved semaglutide for treating MASH, a significant advancement in liver disease management. Semaglutide, previously used for weight loss and diabetes, addresses both weight reduction and liver health, offering a dual benefit. Clinical trials demonstrated that semaglutide led to MASH resolution in 63% of patients without worsening liver scarring, marking a breakthrough for fatty liver disease treatment.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Wage and Tax Slavery, FDA Snubs RFK on Vaccine, Fatty Liver Breakthrough, Michael McNamara, "From Trauma To Joy - The RSB S [Video]

Wage and Tax Slavery, FDA Snubs RFK on Vaccine, Fatty Liver Breakthrough, Michael McNamara, "From Trauma To Joy - The RSB S

TODAY ON THE ROBERT SCOTT BELL SHOW: Wage and Tax Slavery, 5 Drugs Harm Hearing, FDA Snubs RFK on Vaccine, Fatty Liver Breakthrough, Indium Metallicum, Pesticide Bill Hides Risks, Michael McNamara,..

Credit: RumblePublished
MrBeast’s Viral Weight Loss Video Sparks Debate After Tragic Loss Mid-Challenge [Video]

MrBeast’s Viral Weight Loss Video Sparks Debate After Tragic Loss Mid-Challenge

MrBeast’s latest video is going viral, not just for the jaw-dropping weight loss, but for the heartbreaking loss that unfolded mid-challenge. His close friend Madj lost over 100 pounds in 178 days,..

Credit: What's Trending     Duration: 04:27Published